Neuregulin-1 beta regulation of embryonic endothelial progenitor cell survival

作者:Safa Radwan N; Peng Xu Yang; Pentassuglia Laura; Lim Chee Chew; Lamparter Mathias; Silverstein Cheri; Walker Jeremy; Chen Billy; Gei**erg Carrie; Hatzopoulos Antonis K; Sawyer Douglas B*
来源:American Journal of Physiology - Heart and Circulatory Physiology, 2011, 300(4): H1311-H1319.
DOI:10.1152/ajpheart.01104.2009

摘要

Safa RN, Peng XY, Pentassuglia L, Lim CC, Lamparter M, Silverstein C, Walker J, Chen B, Geisberg C, Hatzopoulos AK, Sawyer DB. Neuregulin-1 beta regulation of embryonic endothelial progenitor cell survival. Am J Physiol Heart Circ Physiol 300: H1311-H1319, 2011. First published January 14, 2011; doi:10.1152/ajpheart.01104.2009.-Endothelial progenitor cells (EPCs) are mobilized into the vascular space and home to damaged tissues, where they promote repair in part through a process of angiogenesis. Neuregulins (NRGs) are ligands in the epidermal growth factor family that signal through type I receptor tyrosine kinases in the erbB family (erbB2, erbB3, and erbB4) and regulate endothelial cell biology, promoting angiogenesis. Stimuli such as ischemia and exercise that promote EPC mobilization also induce cleavage and release of transmembrane NRG from cardiac microvascular endothelial cells (CMECs). We hypothesized that NRG/erbB signaling may regulate EPC biology. Using an embryonic (e) EPC cell line that homes to and repairs injured myocardium, we were able to detect erbB2 and erbB3 transcripts. Identical receptor expression was found in EPCs isolated from rat bone marrow and human whole blood. NRG treatment of eEPCs induces phosphorylation of kinases including Akt, GSK-3 beta, and Erk1/2 and the nuclear accumulation and transcriptional activation of beta-catenin. NRG does not induce eEPC proliferation or migration but does protect eEPCs against serum deprivation-induced apoptosis. These results suggest a role for tissue-derived NRG in the regulation of EPC survival.

  • 出版日期2011-4